Biocryst Pharmaceuticals (BCRX) Q2 2026 Earnings

6MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-2.98
-1.97
-0.95
0.06

Details

Expected EPS
0.044267
Actual EPS
-2.98
Surprise EPS
-3.02
Surprise Percent
+6,831.88%

Description

Biocryst Pharmaceuticals (BCRX) has reported earnings of -2.98 per share for Q2 2026.

0 Comments

Share your thoughts